Dr. Andreas Varkaris

Claim this profile

Massachusetts General Hospital

Studies Solid Tumors
Studies Uterine Tumors
3 reported clinical trials
5 drugs studied

Area of expertise

1Solid Tumors
Andreas Varkaris has run 3 trials for Solid Tumors. Some of their research focus areas include:
Stage IV
FGFR positive
FGFR1 positive
2Uterine Tumors
Andreas Varkaris has run 3 trials for Uterine Tumors. Some of their research focus areas include:
Stage IV
FGFR positive
FGFR1 positive

Affiliated Hospitals

Image of trial facility.
Massachusetts General Hospital

Clinical Trials Andreas Varkaris is currently running

Image of trial facility.

Afatinib + Pemigatinib

for Solid Tumors

This study is researching whether the combination of Afatinib and Pemigatinib is safe and effective in FGFR altered unresectable or metastatic advanced solid tumors. The study is also trying to discover the highest doses of the study drugs that can be administered without causing any intolerable side effects. This research study involves the study drugs Afatinib and Pemigatinib.
Recruiting1 award Phase 1

More about Andreas Varkaris

Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Andreas Varkaris has experience with
  • Afatinib
  • Pemigatinib
  • Pembrolizumab
  • TAK-981
  • TTX-MC138-NODAGA-Cu64
Breakdown of trials Andreas Varkaris has run
Solid Tumors
Uterine Tumors
Metastatic Tumor
Cholangiocarcinoma
Bile Duct Cancer

Other Doctors you might be interested in

Suman Srinivasa, MDMassachusetts General Hospital
Daniel C. Chung, MDMassachusetts General Hospital
Gregory Cote, MDMassachusetts General Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andreas Varkaris specialize in?
Andreas Varkaris focuses on Solid Tumors and Uterine Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are FGFR positive.
Is Andreas Varkaris currently recruiting for clinical trials?
Yes, Andreas Varkaris is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Andreas Varkaris has studied deeply?
Yes, Andreas Varkaris has studied treatments such as Afatinib, Pemigatinib, Pembrolizumab.
What is the best way to schedule an appointment with Andreas Varkaris?
Apply for one of the trials that Andreas Varkaris is conducting.
What is the office address of Andreas Varkaris?
The office of Andreas Varkaris is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top